Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie burning — without any signs of nausea.

New weight loss drug target reduces appetite and burns calories without sickness - The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well to current treatments.

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea or loss of muscle mass

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible to millions more individuals.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.